Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Net Cash Flow (2019 - 2025)

Historic Net Cash Flow for AVITA Medical (RCEL) over the last 7 years, with Q4 2025 value amounting to -$5.2 million.

  • AVITA Medical's Net Cash Flow fell 1285.68% to -$5.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$3.8 million, marking a year-over-year increase of 5281.36%. This contributed to the annual value of -$3.8 million for FY2025, which is 5281.36% up from last year.
  • AVITA Medical's Net Cash Flow amounted to -$5.2 million in Q4 2025, which was down 1285.68% from $3.2 million recorded in Q3 2025.
  • Over the past 5 years, AVITA Medical's Net Cash Flow peaked at $55.1 million during Q1 2021, and registered a low of -$50.2 million during Q3 2021.
  • For the 5-year period, AVITA Medical's Net Cash Flow averaged around -$4.2 million, with its median value being -$3.6 million (2024).
  • Per our database at Business Quant, AVITA Medical's Net Cash Flow surged by 82238.24% in 2021 and then plummeted by 62974.05% in 2025.
  • Over the past 5 years, AVITA Medical's Net Cash Flow (Quarter) stood at -$50.2 million in 2021, then surged by 88.66% to -$5.7 million in 2022, then tumbled by 404.57% to -$28.7 million in 2023, then surged by 84.03% to -$4.6 million in 2024, then dropped by 12.86% to -$5.2 million in 2025.
  • Its Net Cash Flow stands at -$5.2 million for Q4 2025, versus $3.2 million for Q3 2025 and -$2.7 million for Q2 2025.